Matsuda, Satoru
Kitagawa, Yuko
Article History
Received: 25 August 2020
Accepted: 3 September 2020
First Online: 15 October 2020
Disclosure
: Yuko Kitagawa received lecture fees from Asahi Kasei Co, Ltd; Taiho Pharmaceutical Company, Ltd; Chugai Pharmaceutical Company, Ltd; EA Pharma Company, Ltd; Yakult Honsha Company, Ltd; Otsuka Pharmaceutical Company, Ltd; Otsuka Pharmaceutical Factory Inc, Shionogi & Company, Ltd; Astellas Pharma, Inc; Dainippon Sumitomo Pharma Company, Ltd; Taisho Toyama Pharmaceutical Company; Ono Pharmaceutical Company; Nihon Pharmaceutical Co, Ltd; Sanofi K.K., Eisai Company, Ltd; and Kaken Pharmaceutical Company, Ltd. Yuko Kitagawa received Grants for research expenses and scholarship from Taiho Pharmaceutical Company, Ltd; Chugai Pharmaceutical Company, Ltd; Yakult Honsha Company, Ltd; Daiichi Sankyo Company, Ltd; Merck Serono Company, Ltd; Asahi Kasei Company, Ltd; EA Pharma Company, Ltd; Otsuka Pharmaceutical Company, Ltd; Takeda Pharmaceutical Company, Ltd; Otsuka Pharmaceutical Factory, Inc; Shionogi Company, Ltd; Kaken Pharmaceutical Company, Ltd; Kowa Pharmaceutical Company, Ltd; Astellas Pharma, Inc; Medicon, Inc; Dainippon Sumitomo Pharma Company, Ltd; Taisho Toyama Pharmaceutical Company, Ltd; Kyouwa Hakkou Kirin Company, Ltd; Pfizer Japan, Inc; Ono Pharmaceutical Company, Ltd; Nihon Pharmaceutical Company, Ltd; Japan Blood Products Organization Medtronic Japan Company, Ltd; Sanofi K.K., Eisai Company, Ltd; Tsumura & Company, Ltd; KCI Licensing, Inc; Abbott Japan Company, Ltd; and Fujifilm, Toyama Chemical Company, Ltd. Yuko Kitagawa worked as a director of endowed chair supported from Taiho Pharmaceutical Company, Ltd; and Chugai Pharmaceutical Company, Ltd. Satoru Matsuda has no conflicts of interest.
Free to read: This content has been made available to all.